Since BRAF and NRAS hotspot mutations are almost mutually exclusive [36] there is close to a 97.6% probability that we would have found either a BRAF or an NRAS hotspot mutation in at least one of the tumours. The gene discussed is NRAS; the disease is neoplasm.